Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7
Clinical trial NCT03761537 · COMPLETED
Trial details
- NCT number
- NCT03761537
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2020-04-21
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.